E-LIB Suche - Ergebnisse für: Ding, J N

1

Tislelizumab versus chemotherapy as second-line treatment f..:

Ajani, J. ; El Hajbi, F. ; Cunningham, D....
ESMO Open. 9 (2024) 1 - p. 102202 , 2024

Link: https://doi.org/10.1016/..

2

Feature space separation by conformity loss driven training..:

Ding, N. ; Arabian, H. ; Möller, K.
IFAC Journal of Systems and Control. 28 (2024) - p. 100260 , 2024

Link: https://doi.org/10.1016/..

3

201P The implementation of first-line pertuzumab and the im..:

Ding, N. ; Hermans, K.E.P.E. ; de Boer, M....
ESMO Open. 9 (2024) - p. 103223 , 2024

Link: https://doi.org/10.1016/..

4

P854 Tofacitinib demonstrates preliminary efficacy in induc..:

Khoo, E ; Amiss, A ; Ding, J N...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1583-i1583 , 2024

Link: https://doi.org/10.1093/..

5

P766 No difference in progression of disability 2 years aft..:

Vieujean, S ; Desseaux, K ; Laharie, D...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1429-i1431 , 2024

Link: https://doi.org/10.1093/..

6

202P Complete response rates, treatment patterns and surviv..:

Ding, N. ; Geurts, S.M.E. ; Tol, J....
ESMO Open. 9 (2024) - p. 103224 , 2024

Link: https://doi.org/10.1016/..

7

P1064 Upadacitinib is safe and effective in Ulcerative Coli..:

Gilmore, R ; Fernandes, R ; Hartley, I...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1913-i1913 , 2024

Link: https://doi.org/10.1093/..

8

9P Prognostic value of baseline neutrophil/lymphocyte ratio..:

Xiao, Z. ; Ding, N. ; Pang, J....
ESMO Open. 8 (2023) 1 - p. 101233 , 2023

Link: https://doi.org/10.1016/..

9

Astroparticle Experiments to Improve the Biological Risk As..:

Bartoloni, A. ; Ding, N. ; Cavoto, G...
Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 1047 (2023) - p. 167738 , 2023

Link: https://doi.org/10.1016/..

10

The mTOR kinase inhibitor everolimus synergistically enhanc..:

Ye, Y. ; Wu, M. ; Mi, L....
Hematological Oncology. 41 (2023) S2 - p. 558-559 , 2023

Link: https://doi.org/10.1002/..

11

CRISPR/CAS9 SCREENING REVEALS SOS1 PARTICIPATE IN ASPARAGIN..:

Wang, D. ; Wang, H. ; Mi, L....
Hematological Oncology. 41 (2023) S2 - p. 801-803 , 2023

Link: https://doi.org/10.1002/..

12

Interaction effect of second particles on the stress concen..:

Tian, L. ; Liu, L. ; Hou, N....
Materialwissenschaft und Werkstofftechnik. 54 (2023) 2 - p. 207-214 , 2023

Link: https://doi.org/10.1002/..

13

SOX2-associated signaling pathways regulate biological phen..:

Ding, L.N. ; Yu, Y.Y. ; Ma, C.J...
Biomedicine & Pharmacotherapy. 160 (2023) - p. 114336 , 2023

Link: https://doi.org/10.1016/..

14

A Time-Sensitive Attribute-Oriented Multi-Message Dynamic S..:

, In: 2023 IEEE International Conference on Smart Internet of Things (SmartIoT),

Ji, Cheng Hui ; Hu, Chuang Ye ; Liu, Zhan Dong. - p. 211-217 , 2023

Link: https://doi.org/10.1109/..

15

Interleukin‐2‐inducible kinase represents a novel therapeut..:

Cao, J. ; Hu, D. ; Yu, H....
Hematological Oncology. 41 (2023) S2 - p. 555-557 , 2023

Link: https://doi.org/10.1002/..